Thursday, July 19, 2012



"implantable radio frequency transponder system for patient identifi...cation and health information."

Page 1004 of the new law (dictating the timing of this chip), reads,
and I quote: "Not later than 36 months after the date of the enactment"

H.R. 3200 section 2521, Pg. 1001, paragraph 1.

"The Secretary shall establish a national medical device registry (in this subsection referred to as the ‘registry’)

to facilitate analysis of post-market safety and outcomes data on each device that— ‘‘is or has been used in or on

a patient; ‘‘and is— ‘‘a class III device; or ‘‘a class II device that is implantable, life-supporting, or life-sustaining.”

A class II implantable device is an "implantable radio frequency transponder system for patient identification and health information." The purpose of a class II device is to collect data in medical patients such as
"claims data, patient survey data, standardized analytic files that
allow for the pooling and analysis of data from disparate data
environments, electronic health records, and any other data deemed
appropriate by the Secretary."

Federal Food, Drug, and Cosmetic Act:

Class III devises are items such as breast implants, pacemakers,
heart valves, etc. A Class II device that is implantable is, as you seen
from the FDA, an implantable radio frequency transponder, RFID chip.
From breast implants, to pacemakers, to RFID chips which one is the only
possible one that can used for the stated purpose in section B which
is, “for linking such data with the information included in the
registry”? As we know from subsection A, the information in the
registry is the name of a device. In plain speak, we are in a clear way
being told that our electronic medical records are going to be linked to
a class II implantable device!

1 comment:

  1. Here is a great website about this: